Pulmonary vascular dysfunction in systemic sclerosis
- PMID: 40145114
- PMCID: PMC11935334
- DOI: 10.1016/j.jhlto.2023.100024
Pulmonary vascular dysfunction in systemic sclerosis
Abstract
Purpose: This study aimed to determine if any cases of pulmonary arterial hypertension (PAH) were missed using routine screening of systemic sclerosis (SSc). We assessed the potential benefits of adding the DETECT algorithm and invasive hemodynamic exercise testing into the local screening process in a Danish single-center cohort without known PAH.
Methods: Seventy-three patients with SSc (aged 60 ± 10 years; 56 (77%) females) underwent echocardiography. Among them, 24/73 had an elevated step 2 score of whom 3 had a high risk of pulmonary hypertension on echocardiographic assessment. Four patients declined right heart catheterization. Twenty patients (aged 62 ± 10 years, 13 (65%) females) underwent invasive hemodynamic assessment at rest. Nineteen patients participated in invasive hemodynamic exercise testing.
Results: At rest, 3/20 patients met the 2022 ESC guidelines for PAH (mean pulmonary arterial pressure (mPAP) >20 mm Hg, pulmonary arterial wedge pressure (PAWP) ≤15 mm Hg, and pulmonary vascular resistance >2 Wood units). According to the 2015 ESC guidelines, only 1/19 patients had PAH. During exercise, 18/19 experienced an mPAP of >30 mm Hg, with the majority (13/19) showing an abnormal pulmonary pressure-flow relationship >3 mm Hg/liter/min. Interestingly, 7 out of 9 patients with no pulmonary hypertension (PH) at rest had exercise-induced pulmonary hypertension. One-quarter of the patients had pulmonary hypertension associated with left ventricular dysfunction (group 2 PH, WHO classification).
Conclusions: In a Danish cohort of 73 patients with SSc already undergoing bi-annual PAH screening, applying the DETECT algorithm identified 3 patients meeting the 2022 ESC/ERS guideline criteria for PAH at rest, 1 of whom demonstrated increased PAWP with exercise. However, many patients exhibited an abnormal pulmonary vascular response to exercise and/or signs of group 2 PH.
Keywords: hemodynamic stress; invasive hemodynamics; pulmonary hypertension; right heart catherterization; systemic sclerosis.
© 2024 International Society for Heart and Lung Transplantation.
Figures


Similar articles
-
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.Arthritis Rheumatol. 2024 May;76(5):777-782. doi: 10.1002/art.42791. Epub 2024 Apr 2. Arthritis Rheumatol. 2024. PMID: 38146100
-
[Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].Ter Arkh. 2015;87(1):49-56. doi: 10.17116/terarkh201587149-56. Ter Arkh. 2015. PMID: 25823269 Clinical Trial. Russian.
-
Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions.Clin Exp Rheumatol. 2024 Aug;42(8):1590-1597. doi: 10.55563/clinexprheumatol/gzo4r2. Epub 2024 Mar 15. Clin Exp Rheumatol. 2024. PMID: 38489342
-
Definitions and diagnosis of pulmonary hypertension.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032. J Am Coll Cardiol. 2013. PMID: 24355641 Review.
-
Surgical Repair of Truncus Arteriosus: A Long-Term Hemodynamic Assessment.World J Pediatr Congenit Heart Surg. 2022 Nov;13(6):716-722. doi: 10.1177/21501351221114779. World J Pediatr Congenit Heart Surg. 2022. PMID: 36300270 Review.
Cited by
-
Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis?Turk J Med Sci. 2025 Feb 18;55(2):404-412. doi: 10.55730/1300-0144.5984. eCollection 2025. Turk J Med Sci. 2025. PMID: 40342320 Free PMC article.
References
-
- Ioannidis J.P., Vlachoyiannopoulos P.G., Haidich A.B., et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005;118:2–10. - PubMed
-
- Khou V., Anderson J.J., Strange G., et al. Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology. 2020;25:863–871. - PubMed
-
- Humbert M., Yaici A., de Groote P., et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63:3522–3530. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous